tirzepatide for breastfeeding Is Mounjaro (tirzepatide) safe to use during breastfeeding? Tirzepatide and Breastfeeding: What Moms

Studies have found that people with overweight or obesity may have a reduction in incretin effects, particularly if they have had frequent weight fluctuations due to yo-yo dieting or if you have undergone bariatric surgery and had weight regain

What is compounded semaglutide or tirzepatide

5 mg/mL concentration: 50 units = 2.5 mg (starting dose, weeks 1-4) 10 mg/mL concentration: 50 units = 5 mg (moderate dose, weeks 5-8) 15 mg/mL concentration: 50 units = 7.5 mg (mid-range dose, weeks 9-12) 17 mg/mL concentration: 50 units = 8.5 mg (between standard tiers) 20 mg/mL concentration: 50 units = 10 mg (high dose, weeks 13-16) 30 mg/mL concentration: 50 units = 15 mg (maximum dose, week 21+) Notice the pattern

Tirzepatide works by addressing multiple pathways involved in appetite, metabolism, and fat storage

In the SURPASS program, gastrointestinal side effects associated with the use of tirzepatide were similar to those observed with semaglutide and GLP1-RA drugs in general, both in terms of frequency and duration [3]